CONTENTS:
- Working with, learning from and giving back: Principles for collaborative research with people who use drugs [Editorial]. Harris M., p. 1953-1956.
- Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map. Wu A.D., Conde M., Butler A.R., Knight E., Lindson N., Livingstone-Banks J., et al., p. 1957-1971.
- Ethical tensions in legally mandated substance use treatment: A scoping review of participant perspectives. Taylor J., Jamakandi S., Saloner B., p. 1972-1981.
- Prevalence of opium use and use disorder in the Iranian population: A systematic review and meta-analysis. Ardeshir M., Rafiemanesh H., Rostam-Abadi Y., Gholami J., Amin-Esmaeili M., Baheshmat S., et al., p. 1982-1997.
- A review of the relationship between dimensions of alcohol consumption and the burden of disease: 2026 update including Mendelian randomisation studies. Carr S., Espinosa Dice A.L., Gmel G.E., Sr., Hassan A.S., Shield K.D., Rehm J., p. 1998-2018.
- Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019-2024. Zhu D.T., Fitzgerald N.D., Palamar J.J., Krotulski A.J., p. 2019-2032.
- Commentary on Zhu et al.: Nitazenes - Tracking a moving target from linked United States databases. Stove C.P., Vandeputte M.M., p. 2033-2034.
- A population-based study exploring racial and gender inequities in polysubstance-related deaths across the United States from 2004 to 2022. Cadet K., Brinzo P., Martins S.S., p. 2035-2042.
- High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis. Rapp-Wright H., Ng K.T., Grant D., Francis W., White M., Evangelopoulos D., et al., p. 2043-2059.
- Excess mortality following discharge from substance use disorder treatment in Chile. Gonzalez-Santa Cruz A., Castillo-Carniglia A., Kaufman J.S., p. 2060-2070.
- The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain-a randomised controlled trial. Nielsen S., Fox F., Lam T., Waddell A., Jung M., Rowland B., et al., p. 2071-2082.
- Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series. Day N., Kaufmann K., Devoe D.J.A., Grubac V., DiMarzo A., Osmanli H., et al., p. 2083-2090.
- Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership. Kronfli N., Popovic N., Weiss E., Stoové M., Lafferty L., Price O., et al., p. 2091-2103.
- Latent classes of sleep deficiency and correlates among patients receiving methadone treatment: A longitudinal study. Hsaio C., Jeon S., DiMeola K.A., Walker K., Akhiwu O., Stein M.D., et al., p. 2104-2115.
- The association between sleep disturbance and stimulant use: A cross-lagged examination. Horigian V.E., Schmidt R.D., Feaster D.J., Duan R., Gonzalez S.T., Hefner K., et al., p. 2116-2126.
- Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis. Qian G.L., Chen Y., Rawson R.A., Humphreys K., Brandeau M.L., p. 2127-2140.
- Efficacy and safety of transcranial direct current stimulation in alcohol use disorder: A randomized controlled triple-blind trial. Trojak B., Sauvaget A., El Hage W., Wallenhorst T., Rolland B., Nubukpo P., et al., p. 2141-2153.
- Age period cohort trends in alcohol treatment episodes across Australia from 2003 to 2022. Yuen W.S., Miller M., Man N., Livingston M., Chrzanowska A., Clare P., et al., p. 2154-2165.
- Predictive value of real-time memory tests in identifying alcohol-induced blackouts in situ. Miller M.B., Shoemaker S.D., Freeman L.K., Curtis A.F., Merrill J.E., Merkle E.C., p. 2166-2175.
- Understanding purchasing patterns of alcoholic, alcohol-free and low-alcohol drinks: A latent profile analysis. Rousham O., Stevely A.K., Holmes J., p. 2176-2185.
- The effect of higher versus lower wattage e-cigarettes on smoking: A randomized controlled trial. Cho Y.J., Hinton A., Nshimiyimana J., Mehta T., Queimado L., Stepanov I., et al., p. 2186-2196.
- Discrimination experiences are associated with same-day and next-day smoking among adults with low socio-economic status trying to quit: A secondary analysis of data from a randomized clinical trial. Boozary L.K., Chen M., Frank-Pearce S.G., Hébert E.T., Chen S., Alexander A.C., et al., p. 2197-2209.
- Longitudinal associations between substance use problem severity and relative harm perceptions of e-cigarettes compared with cigarettes: Results from the United States Population Assessment of Tobacco and Health study (2013-2023). Erinoso O., East K., Streck J., Kasza K., Hyland A., p. 2210-2224.
- All-cause and cause-specific mortality in gambling disorder: Evidence from a nation-wide matched and sibling cohort study in Taiwan. Chen Y.B., Hsu C.W., Wang L.J., Chen M.H., Yang Y.H., Liang C.S., et al., p. 2225-2233.
- Using aggregated ethnicity categories masks inequalities in smoking prevalence in England. Taylor E., Tattan-Birch H., Brown J., Jackson S., p. 2234-2241.
- Regional perspectives on substance use, substance use-related problems and policy: The case of Jordan. Wazaify M., Suyagh M., Yasin H., p. 2242-2251.
- Declining trends in adolescent alcohol consumption and related harms: No room for complacency (an empirical reply to Vieira et al. 2025). Pennington C.R., Shaw D.J., Skubera M., Rose A.K., Jones A., p. 2252-2261.
- Overdose prevention site closure: A reply to Day et al. Crockford D., Colizza K., Grover M., Leary T., Knight E., Martell D., p. 2262-2263.
- Response to Crockford et al.: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series. Day N., Vik S., Tanguay R., Mathew N., Bahji A., p. 2264-2266.